Several balloon-expandable stents have been used in the iliac artery, however, they have not had a primary indication for iliac stenting. The Express® LD iliac premounted stent system (Boston ...

NATICK, Mass., Oct. 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports twelve-month clinical endpoint data from the ORION trial, which demonstrated robust safety and ...

Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release. Boston Scientific said the Epic ...

NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...

"The Epic Stent is a novel stent platform designed to offer both acute and clinical advantages over older-generation stent systems," said Jeff Mirviss, president of the company's peripheral ...

NATICK, Mass. and MIAMI, Jan. 16, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for ...

Boston Scientific ($BSX) won a patent infringement case against a Dr. G. David Jang, who alleged that the device bigwig's Express Stent violated claims of a patent ...

Twelve-Month Data Presented at TCT 2012 Support Safety and Efficacy of Epic Stent in Iliac Stenting NATICK, Mass. -- Boston Scientific Corporation reports twelve-month clinical endpoint data from the ...